Frances E Lock

Title: Frances E Lock: Innovator in Cancer Research

Introduction

Frances E Lock is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of cancer research, particularly in the detection and treatment of cancer stem cells. Her innovative work has led to the development of valuable methods and tools that enhance cancer prognosis and treatment efficacy.

Latest Patents

Frances E Lock holds a patent for "Carbonic anhydrase IX-related markers and use thereof." This patent provides methods for detecting the presence of cancer stem cells and their application in cancer prognosis, evaluating the risk of cancer metastasis, identifying or validating drug candidates, and determining treatment efficacy. Additionally, it includes kits useful for detecting cancer stem cells and methods for treating cancer using CAIX inhibitors.

Career Highlights

Throughout her career, Frances has worked with notable organizations such as SignalChem Lifesciences Corporation and the British Columbia Cancer Agency. Her work in these institutions has been instrumental in advancing cancer research and developing innovative solutions for cancer treatment.

Collaborations

Frances has collaborated with esteemed colleagues, including Paul Christopher McDonald and Shoukat Dedhar. These partnerships have further enriched her research and contributed to the success of her projects.

Conclusion

Frances E Lock is a trailblazer in cancer research, with her patent and career achievements reflecting her dedication to improving cancer treatment and prognosis. Her innovative contributions continue to impact the field significantly.